MLYS logo

Mineralys Therapeutics (MLYS) Selling, general & administrative expenses

annual SGA:

$23.82M+$9.53M(+66.63%)
December 31, 2024

Summary

  • As of today (June 17, 2025), MLYS annual SGA is $23.82 million, with the most recent change of +$9.53 million (+66.63%) on December 31, 2024.
  • During the last 3 years, MLYS annual SGA has risen by +$21.41 million (+885.60%).
  • MLYS annual SGA is now at all-time high.

Performance

MLYS SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSincome statement metrics

quarterly SGA:

$6.57M-$630.00K(-8.75%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLYS quarterly SGA is $6.57 million, with the most recent change of -$630.00 thousand (-8.75%) on March 31, 2025.
  • Over the past year, MLYS quarterly SGA has increased by +$1.96 million (+42.53%).
  • MLYS quarterly SGA is now -8.75% below its all-time high of $7.20 million, reached on December 31, 2024.

Performance

MLYS quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSincome statement metrics

TTM SGA:

-$1.10B-$188.51M(-20.73%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLYS TTM SGA is -$1.10 billion, with the most recent change of -$188.51 million (-20.73%) on March 31, 2025.
  • Over the past year, MLYS TTM SGA has dropped by -$1.11 billion (-6853.48%).
  • MLYS TTM SGA is now -4671.84% below its all-time high of -$23.01 million.

Performance

MLYS TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

MLYS Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+66.6%+42.5%-6853.5%
3 y3 years+885.6%+730.3%-10000.0%
5 y5 years+4377.8%+1306.4%-10000.0%

MLYS Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+885.6%-8.8%+643.0%-1545.1%at low
5 y5-yearat high+4377.8%-8.8%+1306.4%-4671.8%at low
alltimeall timeat high+4377.8%-8.8%+1306.4%-4671.8%at low

MLYS Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$6.57M(-8.8%)
$25.78M(+8.2%)
Dec 2024
$23.82M(+66.6%)
$7.20M(+17.6%)
$23.82M(+15.4%)
Sep 2024
-
$6.12M(+3.8%)
$20.65M(+12.8%)
Jun 2024
-
$5.89M(+27.9%)
$18.30M(+12.6%)
Mar 2024
-
$4.61M(+14.5%)
$16.26M(+13.7%)
Dec 2023
$14.30M
$4.03M(+6.7%)
$14.30M(+14.7%)
Sep 2023
-
$3.77M(-2.0%)
$12.46M(+24.0%)
Jun 2023
-
$3.85M(+45.6%)
$10.05M(+41.9%)
DateAnnualQuarterlyTTM
Mar 2023
-
$2.65M(+20.8%)
$7.08M(+35.5%)
Dec 2022
$5.23M(+116.3%)
$2.19M(+60.6%)
$5.23M(+49.1%)
Sep 2022
-
$1.36M(+54.3%)
$3.51M(+63.7%)
Jun 2022
-
$884.00K(+11.8%)
$2.14M(+70.3%)
Mar 2022
-
$791.00K(+69.4%)
$1.26M(+169.4%)
Dec 2021
$2.42M(+354.3%)
-
-
Dec 2021
-
$467.00K
$467.00K
Dec 2020
$532.00K
-
-

FAQ

  • What is Mineralys Therapeutics annual SGA?
  • What is the all time high annual SGA for Mineralys Therapeutics?
  • What is Mineralys Therapeutics annual SGA year-on-year change?
  • What is Mineralys Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Mineralys Therapeutics?
  • What is Mineralys Therapeutics quarterly SGA year-on-year change?
  • What is Mineralys Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Mineralys Therapeutics?
  • What is Mineralys Therapeutics TTM SGA year-on-year change?

What is Mineralys Therapeutics annual SGA?

The current annual SGA of MLYS is $23.82M

What is the all time high annual SGA for Mineralys Therapeutics?

Mineralys Therapeutics all-time high annual SGA is $23.82M

What is Mineralys Therapeutics annual SGA year-on-year change?

Over the past year, MLYS annual SGA has changed by +$9.53M (+66.63%)

What is Mineralys Therapeutics quarterly SGA?

The current quarterly SGA of MLYS is $6.57M

What is the all time high quarterly SGA for Mineralys Therapeutics?

Mineralys Therapeutics all-time high quarterly SGA is $7.20M

What is Mineralys Therapeutics quarterly SGA year-on-year change?

Over the past year, MLYS quarterly SGA has changed by +$1.96M (+42.53%)

What is Mineralys Therapeutics TTM SGA?

The current TTM SGA of MLYS is -$1.10B

What is the all time high TTM SGA for Mineralys Therapeutics?

Mineralys Therapeutics all-time high TTM SGA is -$23.01M

What is Mineralys Therapeutics TTM SGA year-on-year change?

Over the past year, MLYS TTM SGA has changed by -$1.11B (-6853.48%)
On this page